RSS Feed
Search Ask-Cato.com
Tags
adverse events biologics biomarkers biosimilar biotech cancer Cato BioVentures Cato Research CDER clinical investigator clinical research clinical trials CMC conference CROs DIA drug development eCTD efficacy FDA funding GlobalSubmit guidance Health Canada IND in vitro diagnostics manufacturing marketing application medical devices NDA NIH nonclinical research oncology Phase 1 Phase 2 PMA postmarketing protocol safety statistical analysis toxicology transparency vaccines venture capital webinarCategories
- Clinical Trials (55)
- Conferences and Meetings (35)
- eCTD (26)
- FDA (78)
- Guest Posts (5)
- Health Canada (6)
- Industry News (62)
- Project Management (1)
- Publications (7)
- Regulatory Strategy (39)
- Social Media (6)
- Statistics (9)
- Uncategorized (1)
- Venture Capital (10)
- Webinars (24)
Tag Archives: guest post
Advice from the FDA, Part 1: Technical Errors to Avoid in Your eCTD Submissions
Cato’s Director of Regulatory Operations, Evan Richardson, authored a guest blog post featured on PharmPro.com today. PharmPro.com is the website for Pharmaceutical Processing magazine, offering a wealth of information on products, technologies and applications for pharmaceutical and biopharmaceutical professionals. Evan’s … Continue reading
Posted in eCTD, Guest Posts, Publications, Social Media
Tagged best practices, eCTD, FDA, guest post, PharmPro.com, submissions
Comments Off
